Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Dibs, the contract value may not be large but I think you are missing the point when you call it “derisory”. The importance of the contract is that it is a foot in the door of a major pharmaceutical company.
AS himself, in today’s interview, acknowledged that £150,000 is a small amount of money, but it has a “massive flow through potential”. AGL will aim to build on this new relationship with AstraZeneca. AN also referred to
“the halo effect of working with AstraZeneca” and that “they are a critical reference customer for the rest of our business.” It is a huge endorsement of AGL and Parsortix to be used by a company of the stature of AstraZeneca, who are a genuine household name.
Another positive is that the DDR assay developed and paid for by Artios is being used and developed further for AstraZeneca’s requirements. So, not only have AGL been paid to develop the Artois assay, but it can then be offered to other customers.
I think it’s a great result from the AGL team.
1 mm waiting on 22. Brakes off
Ticking up nicely although I see that every time a chunky buy goes through it is followed by a sell. Looks to me like someone is short here and is trying to depress the sp.
I agree BrnetPeter. LSE is behaving like a 3rd world market. Is it any wonder companies are delisting. However AGL has a US presence in the OTC market I think - ticker ANPCY. I know I will be corrected if I'm wrong about this!!
NG
AGL does well in the afternoon after a cracking RNS
20p finish my prediction, slowly but surely this will re-rate IMHO
Not Investment Advice
Always DYOR
Treeman remember when you used to ramp SCE ON THIS BOARD when it was 70p, where is it now 3p. You used to praise the DCE board.. you don't have a clue do you?
If this was fully listed in the USA the price would be nearly one pound. The company could raise 50 million dollars of new money. The buyers would be piling in today. The Lse is pathetic
Hi Bantham,
Yeah certainly the market is more cautious of spikes after the last rise to 35p. So, hopefully we might see a more gradual organic rise in the coming weeks.
Over the past couple of months I’ve traded in and out about 10-15% of my holding to increase my core position so now holding a decent amount for the long game.
US investors will push this higher.
In the Jan presentation management said main investors our from the US.
Ah Earl you just cannot help yourself can you. I just knew you would be pumping something else for your daily 2-5%.
Better off buying AGL looks like it's going to push on despite me thinking it would go quiet, this is how the super spike of 12-37p started, got to 16-17p looked like it would go dead then in the afternoon it hit a new intraday high and then went nuts. Got to break 17.5p for that here today
Very bullish interview
Tens of millions of pound opportunity
More contracts on the way
Always DYOR
Not Investment Advice
No placing funded till 2025. . Scare Mongering peeps trying to talk this down. Get a life
Https://www.youtube.com/watch?v=IV9VdZoaL9o
From 21 mins
I bailed first thing with meagre profit, staying out now until financing and cap structure has better visibility.
Good luck all, thought todays news was exciting and hopefully good for long termers.
It’s just that the market still seems more focussed on cash runway/b-even and number of shares that will be in issue by time b/even occurs.
EC - nobody who buys AGL thinks parsortix is rubbish. That’s not their concern.
If you can’t see the issue now you never will.
No offence and hope it pays you big over long term.
Well done holders,
another Huge company sitting quite now,
with Billions of Heart valve sector
go and see for yourself RUA... (cashed up for 4 years)
'the MMs are holding it down for mates rates'?? seriously , maybe just maybe its people off loading as they have made their profit. Im guessing this ends at 13p
See these, and where this is going I believe..............
https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html
https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-astrazeneca-edeymgqdtcshqde.html
The following one is ALL IMPORTANT !!!! Join the dots............
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
NT to buy. Mms holding it down for mates rates
So this 'deal' is worth £150,000 over 6 months and the market cap rises £8 million. ok....
An agreement with such a big name. Considering the low level of the SP yesterday (on a 5-year chart) I would have thought that a 90% rise was more appropriate, and to the point. Such a weak market this, on AIM, for responding to good news....
Hi TomHuk
Yes that is most certainly large pharma. But it’s a pretty puny deal. Nonetheless - yes that’s progress.
In fact to me it’s bigger news than the January news - but the punters are beginning to see the Emperor’s new clothes for what they are. So the share price appears not to be spiking in the same way - but maybe it will over the next 48 hours.
BTW - it did spike and drop last time didn’t it?
You tempted to build your position?
A derisory deal and notice that Astro Zeneca themselves did not even make any comment on the deal. That’s how highly it registers on their radar.
This is basically Angle saying don’t worry we’ll do it effectively for free and hope you throw us a few breadcrumbs. £150k for six months work!? Do me a favour. It is NOT a big deal.
Newland trying to pump the SP for the next begging bowl.
I cannot see it doing what it did before when it went from 12p to 37p in 2 days, the market is just not there atm and also saturated with day traders who will halt any rise taking 0.5p if they can get it. Also people are nervous about the cash side of the business, they want to see results and see exactly what they have left and how much turnover has jumped so I will be surprised if it pushes on this time
Up more - 32%.
18p plus on the cards.
All IMHO.